<p>根據最近向證券交易委員會（SEC）提交的文件，弗吉尼亞退休系統（VIRGINIA RETIREMENT SYSTEMS ET Al）在第四季度削減了對 Globus Medical, Inc.（NYSE:GMED - 免費報告）的持股 58.0%。該公司在季度內出售了 17,300 股後，持有 12,510 股該醫療設備公司的股票。截至最近的 SEC 文件，弗吉尼亞退休系統在 Globus Medical 的持股價值為 1,092,000 美元。</p>
<p>其他幾家對沖基金和機構投資者也對 GMED 的持股進行了增減。AQR Capital Management LLC 在第一季度將其在 Globus Medical 的持股增加了 45.9%。AQR Capital Management LLC 目前持有 22,510 股該醫療設備公司的股票，價值 1,622,000 美元，此前在該期間內又購買了 7,086 股。Integrated Wealth Concepts LLC 在第一季度將其在 Globus Medical 的持股增加了 33.0%。Integrated Wealth Concepts LLC 目前持有 4,375 股該醫療設備公司的股票，價值 320,000 美元，此前在該期間內又購買了 1,085 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Globus Medical 的持股增加了 38.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 30,649 股該醫療設備公司的股票，價值 2,228,000 美元，此前在該期間內又購買了 8,540 股。Jones Financial Companies Lllp 在第一季度將其在 Globus Medical 的持股增加了 237.3%。Jones Financial Companies Lllp 目前持有 850 股該醫療設備公司的股票，價值 62,000 美元，此前在該期間內又購買了 598 股。最後，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度將其在 Globus Medical 的持股增加了 8.8%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前持有 347,527 股該醫療設備公司的股票，價值 25,439,000 美元，此前在該期間內又購買了 28,027 股。當前 95.16% 的股票由機構投資者持有。</p>
<p>獲取 <strong>Globus Medical</strong> 的提醒：</p>
<h2>分析師設定新目標價</h2>
<p>幾位研究分析師對 GMED 股票發表了看法。Truist Financial 在 2 月 25 日的研究報告中將 Globus Medical 的目標價設定為 115.00 美元。加拿大皇家銀行在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 115.00 美元上調至 120.00 美元，並給予該股票 “跑贏大盤” 的評級。富國銀行在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 104.00 美元下調至 103.00 美元，併為該公司設定了 “增持” 評級。Needham &amp; Company LLC 在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 114.00 美元上調至 117.00 美元，並給予該公司 “買入” 評級。最後，Zacks Research 在 3 月 3 日的研究報告中將 Globus Medical 的評級從 “持有” 上調至 “強烈買入”。兩位分析師給予該股票 “強烈買入” 評級，九位給予 “買入” 評級，五位給予 “持有” 評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 106.36 美元。</p>
<p><strong>閲讀我們關於 Globus Medical 的最新股票報告</strong></p>
<h2>Globus Medical 的內部交易</h2>
<p>在相關消息中，執行副總裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。該股票以 94.50 美元的平均價格出售，總價值為 1,890,000.00 美元。該交易已在向證券交易委員會的文件中披露，相關文件可通過此鏈接獲取。當前 18.38% 的股票由公司內部人士持有。</p>
<h2>Globus Medical 股票下跌 0.9%</h2>
<p>GMED 的股票在週五開盤價為 76.52 美元。該公司的市值為 103.9 億美元，市盈率為 17.79，市盈率/增長比率為 1.58，貝塔值為 1.00。該公司的 50 日移動平均線為 87.78 美元，200 日移動平均線為 87.08 美元。Globus Medical, Inc.的 52 周低點為 51.79 美元，52 周高點為 101.40 美元。</p>
<p>Globus Medical（NYSE:GMED - 獲取免費報告）最近在 5 月 7 日發佈了季度財報。該醫療設備公司報告每股收益（EPS）為 1.12 美元，超出分析師一致預期的 0.92 美元，超出幅度為 0.20 美元。該公司在季度內的收入為 7.5985 億美元，而一致預期為 7.4035 億美元。Globus Medical 的股本回報率為 13.46%，淨利潤率為 18.92%。Globus Medical 的收入同比增長 27.0%。去年同期，該公司每股收益為 0.68 美元。Globus Medical 已將其 2026 財年的指導目標設定為 4.700-4.800 EPS。整體來看，研究分析師預計 Globus Medical, Inc.在當前財年將發佈 4.74 的每股收益。</p>
<h2>Globus Medical 簡介</h2>
<p>（免費報告）</p>
<p>Globus Medical, Inc. NYSE: GMED 是一家領先的醫療設備公司，專注於脊柱和骨科應用的肌肉骨骼解決方案。該公司於 2003 年由 David C. Paul 創立，總部位於賓夕法尼亞州 Audubon，開發、製造和銷售旨在治療脊柱疾病和促進骨癒合的植入設備和外科器械。其產品組合包括用於微創和開放手術的解決方案，包括椎間融合設備、椎弓根螺釘系統和用於增強融合效果的生物製劑。</p>
<p>除了其核心脊柱業務外，Globus Medical 還擴展到機器人和導航系統，以支持手術室的精確性和效率。</p>
<h2>另請參閲</h2>
<ul>
<li>我們更看好的五隻股票比 Globus Medical 更好</li>
<li>如果油價持續上漲，值得擁有的三隻股票</li>
<li>分析師喜愛的三家關鍵航空航天組件製造商</li>
<li>Alphabet 的 Googlebook 將 Gemini AI 帶入 PC 硬件</li>
<li>Peloton 股票在樂觀的財報後回吐漲幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Globus Medical 嗎？</h2>
<p>在考慮 Globus Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Globus Medical 並不在名單上。</p>
<p>雖然 Globus Medical 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Globus醫療

<p>維吉尼亞退休系統等在第四季度減少了對 Globus Medical, Inc.（紐約證券交易所代碼：GMED）58% 的持股，出售了 17,300 股。該公司目前持有 12,510 股，價值 1,092,000 美元。其他機構投資者也調整了他們的持股，AQR 資本管理公司將其持股增加了 45.9%。分析師為 GMED 設定了價格目標，平均目標為 106.36 美元。該股票開盤價為 76.52 美元，市值為 103.9 億美元，最近的財報顯示同比收入增長 27%</p>

<p>VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 58.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,510 shares of the medical device company's stock after selling 17,300 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al's holdings in Globus Medical were worth $1,092,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根據最近向證券交易委員會（SEC）提交的文件，弗吉尼亞退休系統（VIRGINIA RETIREMENT SYSTEMS ET Al）在第四季度削減了對 Globus Medical, Inc.（NYSE:GMED - 免費報告）的持股 58.0%。該公司在季度內出售了 17,300 股後，持有 12,510 股該醫療設備公司的股票。截至最近的 SEC 文件，弗吉尼亞退休系統在 Globus Medical 的持股價值為 1,092,000 美元。</p>
</div><p>Several other hedge funds and other institutional investors have also added to or reduced their stakes in GMED. AQR Capital Management LLC boosted its stake in Globus Medical by 45.9% in the 1st quarter. AQR Capital Management LLC now owns 22,510 shares of the medical device company's stock worth $1,622,000 after purchasing an additional 7,086 shares during the period. Integrated Wealth Concepts LLC boosted its stake in Globus Medical by 33.0% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,375 shares of the medical device company's stock worth $320,000 after purchasing an additional 1,085 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Globus Medical by 38.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,649 shares of the medical device company's stock worth $2,228,000 after purchasing an additional 8,540 shares during the period. Jones Financial Companies Lllp boosted its stake in Globus Medical by 237.3% in the 1st quarter. Jones Financial Companies Lllp now owns 850 shares of the medical device company's stock worth $62,000 after purchasing an additional 598 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Globus Medical by 8.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 347,527 shares of the medical device company's stock worth $25,439,000 after purchasing an additional 28,027 shares during the period. 95.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者也對 GMED 的持股進行了增減。AQR Capital Management LLC 在第一季度將其在 Globus Medical 的持股增加了 45.9%。AQR Capital Management LLC 目前持有 22,510 股該醫療設備公司的股票，價值 1,622,000 美元，此前在該期間內又購買了 7,086 股。Integrated Wealth Concepts LLC 在第一季度將其在 Globus Medical 的持股增加了 33.0%。Integrated Wealth Concepts LLC 目前持有 4,375 股該醫療設備公司的股票，價值 320,000 美元，此前在該期間內又購買了 1,085 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Globus Medical 的持股增加了 38.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 30,649 股該醫療設備公司的股票，價值 2,228,000 美元，此前在該期間內又購買了 8,540 股。Jones Financial Companies Lllp 在第一季度將其在 Globus Medical 的持股增加了 237.3%。Jones Financial Companies Lllp 目前持有 850 股該醫療設備公司的股票，價值 62,000 美元，此前在該期間內又購買了 598 股。最後，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度將其在 Globus Medical 的持股增加了 8.8%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前持有 347,527 股該醫療設備公司的股票，價值 25,439,000 美元，此前在該期間內又購買了 28,027 股。當前 95.16% 的股票由機構投資者持有。</p>
</div><p>Get <strong>Globus Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Globus Medical</strong> 的提醒：</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several research analysts have weighed in on GMED shares. Truist Financial set a $115.00 price target on Globus Medical in a research note on Wednesday, February 25th. Royal Bank Of Canada upped their price target on Globus Medical from $115.00 to $120.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday, May 8th. Wells Fargo &amp; Company dropped their price target on Globus Medical from $104.00 to $103.00 and set an &#34;overweight&#34; rating for the company in a research note on Friday, May 8th. Needham &amp; Company LLC increased their target price on Globus Medical from $114.00 to $117.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, May 8th. Finally, Zacks Research upgraded Globus Medical from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $106.36.</p>
<div class="lb-trans"><p>幾位研究分析師對 GMED 股票發表了看法。Truist Financial 在 2 月 25 日的研究報告中將 Globus Medical 的目標價設定為 115.00 美元。加拿大皇家銀行在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 115.00 美元上調至 120.00 美元，並給予該股票 “跑贏大盤” 的評級。富國銀行在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 104.00 美元下調至 103.00 美元，併為該公司設定了 “增持” 評級。Needham &amp; Company LLC 在 5 月 8 日的研究報告中將 Globus Medical 的目標價從 114.00 美元上調至 117.00 美元，並給予該公司 “買入” 評級。最後，Zacks Research 在 3 月 3 日的研究報告中將 Globus Medical 的評級從 “持有” 上調至 “強烈買入”。兩位分析師給予該股票 “強烈買入” 評級，九位給予 “買入” 評級，五位給予 “持有” 評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 106.36 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Globus Medical</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Globus Medical 的最新股票報告</strong></p>
</div><h2>Insider Transactions at Globus Medical</h2>
<div class="lb-trans"><h2>Globus Medical 的內部交易</h2>
</div><p>In related news, EVP Kelly Huller sold 20,000 shares of the firm's stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $94.50, for a total value of $1,890,000.00. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. 18.38% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，執行副總裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。該股票以 94.50 美元的平均價格出售，總價值為 1,890,000.00 美元。該交易已在向證券交易委員會的文件中披露，相關文件可通過此鏈接獲取。當前 18.38% 的股票由公司內部人士持有。</p>
</div><h2>Globus Medical Stock Down 0.9%</h2>
<div class="lb-trans"><h2>Globus Medical 股票下跌 0.9%</h2>
</div><p>Shares of GMED opened at $76.52 on Friday. The company has a market cap of $10.39 billion, a PE ratio of 17.79, a P/E/G ratio of 1.58 and a beta of 1.00. The business has a fifty day moving average of $87.78 and a 200 day moving average of $87.08. Globus Medical, Inc. has a 52-week low of $51.79 and a 52-week high of $101.40.</p>
<div class="lb-trans"><p>GMED 的股票在週五開盤價為 76.52 美元。該公司的市值為 103.9 億美元，市盈率為 17.79，市盈率/增長比率為 1.58，貝塔值為 1.00。該公司的 50 日移動平均線為 87.78 美元，200 日移動平均線為 87.08 美元。Globus Medical, Inc.的 52 周低點為 51.79 美元，52 周高點為 101.40 美元。</p>
</div><p>Globus Medical (NYSE:GMED - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The medical device company reported $1.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.92 by $0.20. The company had revenue of $759.85 million during the quarter, compared to the consensus estimate of $740.35 million. Globus Medical had a return on equity of 13.46% and a net margin of 18.92%.Globus Medical's revenue was up 27.0% on a year-over-year basis. During the same period last year, the company earned $0.68 earnings per share. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. As a group, research analysts anticipate that Globus Medical, Inc. will post 4.74 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Globus Medical（NYSE:GMED - 獲取免費報告）最近在 5 月 7 日發佈了季度財報。該醫療設備公司報告每股收益（EPS）為 1.12 美元，超出分析師一致預期的 0.92 美元，超出幅度為 0.20 美元。該公司在季度內的收入為 7.5985 億美元，而一致預期為 7.4035 億美元。Globus Medical 的股本回報率為 13.46%，淨利潤率為 18.92%。Globus Medical 的收入同比增長 27.0%。去年同期，該公司每股收益為 0.68 美元。Globus Medical 已將其 2026 財年的指導目標設定為 4.700-4.800 EPS。整體來看，研究分析師預計 Globus Medical, Inc.在當前財年將發佈 4.74 的每股收益。</p>
</div><h2>Globus Medical Profile</h2>
<div class="lb-trans"><h2>Globus Medical 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Globus Medical, Inc NYSE: GMED is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.</p>
<div class="lb-trans"><p>Globus Medical, Inc. NYSE: GMED 是一家領先的醫療設備公司，專注於脊柱和骨科應用的肌肉骨骼解決方案。該公司於 2003 年由 David C. Paul 創立，總部位於賓夕法尼亞州 Audubon，開發、製造和銷售旨在治療脊柱疾病和促進骨癒合的植入設備和外科器械。其產品組合包括用於微創和開放手術的解決方案，包括椎間融合設備、椎弓根螺釘系統和用於增強融合效果的生物製劑。</p>
</div><p>In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.</p>
<div class="lb-trans"><p>除了其核心脊柱業務外，Globus Medical 還擴展到機器人和導航系統，以支持手術室的精確性和效率。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參閲</h2>
</div><ul>
<li>Five stocks we like better than Globus Medical</li>
<li>3 Stocks to Own If Gas Prices Keep Rising</li>
<li>3 Crucial Aerospace Component Makers That Analysts Love</li>
<li>Alphabet's Googlebook Brings Gemini AI to PC Hardware</li>
<li>Peloton Stock Gives Back Gains After Upbeat Earnings Report</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Globus Medical 更好</li>
<li>如果油價持續上漲，值得擁有的三隻股票</li>
<li>分析師喜愛的三家關鍵航空航天組件製造商</li>
<li>Alphabet 的 Googlebook 將 Gemini AI 帶入 PC 硬件</li>
<li>Peloton 股票在樂觀的財報後回吐漲幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=GMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Globus Medical 嗎？</h2>
</div><p>Before you consider Globus Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Globus Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Globus Medical 並不在名單上。</p>
</div><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Globus Medical 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

VIRGINIA RETIREMENT SYSTEMS ET Al Sells 17,300 Shares of Globus Medical, Inc. $GMED

Market Beat

Truist Financial

加拿大皇家銀行

富國銀行

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

弗吉尼亞退休系統等機構出售了 17,300 股 Globus 醫療公司的股票，代碼為$GMED